AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
EVIDENCE FOR A PROSTATE-CANCER SUSCEPTIBILITY LOCUS ON THE X-CHROMOSOME
Authors: XU JF MEYERS D FREIJE D ISAACS S WILEY K NUSSKERN D EWING C WILKENS E BUJNOVSZKY P BOVA GS WALSH P ISAACS W SCHLEUTKER J MATIKAINEN M TAMMELA T VISAKORPI T KALLIONIEMI OP BERRY R SCHAID D FRENCH A MCDONNELL S SCHROEDER J BLUTE M THIBODEAU S GRONBERG H EMANUELSSON M DAMBER JE BERGH A JONSSON BA SMITH J BAILEYWILSON J CARPTEN J STEPHAN D GILLANDERS E AMUNDSON I KAINU T FREASLUTZ D BAFFOEBONNIE A VANAUCKEN A SOOD R COLLINS F BROWNSTEIN M TRENT J
Citation: Jf. Xu et al., EVIDENCE FOR A PROSTATE-CANCER SUSCEPTIBILITY LOCUS ON THE X-CHROMOSOME, Nature genetics, 20(2), 1998, pp. 175-179
LOCALIZATION OF 1,25-DIHYDROXYVITAMIN D-3 RECEPTOR (VDR) EXPRESSION IN HUMAN PROSTATE
Authors: KIVINEVA M BLAUER M SYVALA H TAMMELA T TUOHIMAA P
Citation: M. Kivineva et al., LOCALIZATION OF 1,25-DIHYDROXYVITAMIN D-3 RECEPTOR (VDR) EXPRESSION IN HUMAN PROSTATE, Journal of steroid biochemistry and molecular biology, 66(3), 1998, pp. 121-127
EXPLORATORY POST-HOC SURVIVAL EVALUATION IN M1 PROSTATE-CANCER PATIENTS TREATED WITH BICALUTAMIDE (CASODEX)
Authors: KAISARY AV IVERSEN P TYRRELL CJ ANDERSON J VANPOPPEL H TAMMELA T CHAMBERLAIN M
Citation: Av. Kaisary et al., EXPLORATORY POST-HOC SURVIVAL EVALUATION IN M1 PROSTATE-CANCER PATIENTS TREATED WITH BICALUTAMIDE (CASODEX), Annals of oncology, 9, 1998, pp. 273-273
RANDOMIZED COMPARISON OF CASODEX(TM) (BICALUTAMIDE) 150 MG MONOTHERAPY VERSUS CASTRATION IN THE TREATMENT OF METASTATIC AND LOCALLY ADVANCED PROSTATE-CANCER
Authors: TYRRELL CJ KAISARY AV IVERSEN P ANDERSON JB BAERT L TAMMELA T CHAMBERLAIN M WEBSTER A BLACKLEDGE G
Citation: Cj. Tyrrell et al., RANDOMIZED COMPARISON OF CASODEX(TM) (BICALUTAMIDE) 150 MG MONOTHERAPY VERSUS CASTRATION IN THE TREATMENT OF METASTATIC AND LOCALLY ADVANCED PROSTATE-CANCER, European urology, 33(5), 1998, pp. 447-456
CASODEX (BICALUTAMIDE) 150-MG MONOTHERAPY COMPARED WITH CASTRATION INPATIENTS WITH PREVIOUSLY UNTREATED NONMETASTATIC PROSTATE-CANCER - RESULTS FROM 2 MULTICENTER RANDOMIZED TRIALS AT A MEDIAN FOLLOW-UP OF 4 YEARS
Authors: IVERSEN P TYRRELL CJ KAISARY AV ANDERSON JB BAERT L TAMMELA T CHAMBERLAIN M CARROLL K GOTTINGSMITH K BLACKLEDGE GRP
Citation: P. Iversen et al., CASODEX (BICALUTAMIDE) 150-MG MONOTHERAPY COMPARED WITH CASTRATION INPATIENTS WITH PREVIOUSLY UNTREATED NONMETASTATIC PROSTATE-CANCER - RESULTS FROM 2 MULTICENTER RANDOMIZED TRIALS AT A MEDIAN FOLLOW-UP OF 4 YEARS, Urology, 51(3), 1998, pp. 389-396
CONTINUED IMPROVEMENT OVER 2 YEARS IN PRESSURE-FLOW PARAMETERS IN MENON FINASTERIDE
Authors: BARRETT D TAMMELA T ABRAMS P HEDLUND H ROLLEMA H NORDLING J ANDERSEN J HALD T MATOSFERRIERA A BRUSKEWITZ R MILLER P KIRBY R MALICE MP BACH MA JACOBSEN CA SCHAFER W
Citation: D. Barrett et al., CONTINUED IMPROVEMENT OVER 2 YEARS IN PRESSURE-FLOW PARAMETERS IN MENON FINASTERIDE, The Journal of urology, 159(5), 1998, pp. 1278-1278
PROSPECTS FOR IMPROVING SURVIVAL IN EARLY PROSTATE-CANCER - RESULTS AND ONGOING STUDIES WITH THE NONSTEROIDAL ANTIANDROGEN BICALUTAMIDE (CASODEX)
Authors: IVERSEN P TYRRELL CJ KAISARY AV ANDERSON JB BAERT L TAMMELA T CHAMBERLAIN M
Citation: P. Iversen et al., PROSPECTS FOR IMPROVING SURVIVAL IN EARLY PROSTATE-CANCER - RESULTS AND ONGOING STUDIES WITH THE NONSTEROIDAL ANTIANDROGEN BICALUTAMIDE (CASODEX), The Journal of urology, 159(5), 1998, pp. 1301-1301
BENIGN PROSTATIC HYPERPLASIA - PRACTICAL TREATMENT GUIDELINES
Authors: TAMMELA T
Citation: T. Tammela, BENIGN PROSTATIC HYPERPLASIA - PRACTICAL TREATMENT GUIDELINES, Drugs & aging, 10(5), 1997, pp. 349-366
IFOSFAMIDE (IFO) IN THE TREATMENT OF METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER
Authors: KELLOKUMPULEHTINEN P LEHTINEN T TAMMELA T
Citation: P. Kellokumpulehtinen et al., IFOSFAMIDE (IFO) IN THE TREATMENT OF METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER, European journal of cancer, 33, 1997, pp. 128-128
BIOABSORBABLE AND BIODEGRADABLE STENTS IN UROLOGY
Authors: TALJA M VALIMAA T TAMMELA T PETAS A TORMALA P
Citation: M. Talja et al., BIOABSORBABLE AND BIODEGRADABLE STENTS IN UROLOGY, Journal of endourology, 11(6), 1997, pp. 391-397
ANTIBIOTIC-PROPHYLAXIS IN PATIENTS WITH URINARY RETENTION UNDERGOING TRANSURETHRAL PROSTATECTOMY
Authors: LUKKARINEN O HELLSTROM P LEPPILAHTI M KONTTURI M TAMMELA T
Citation: O. Lukkarinen et al., ANTIBIOTIC-PROPHYLAXIS IN PATIENTS WITH URINARY RETENTION UNDERGOING TRANSURETHRAL PROSTATECTOMY, Annales chirurgiae et gynaecologiae, 86(3), 1997, pp. 239-242
IMMUNODETECTION OF ANDROGEN RECEPTOR IN HUMAN URINARY-BLADDER CANCER
Authors: ZHUANG YH BLAUER M TAMMELA T TUOHIMAA P
Citation: Yh. Zhuang et al., IMMUNODETECTION OF ANDROGEN RECEPTOR IN HUMAN URINARY-BLADDER CANCER, Histopathology, 30(6), 1997, pp. 556-562
ANDROGEN RECEPTOR GENE AMPLIFICATION IN A RECURRENT PROSTATE-CANCER AFTER MONOTHERAPY WITH THE NONSTEROIDAL POTENT ANTIANDROGEN CASODEX (BICALUTAMIDE) WITH A SUBSEQUENT FAVORABLE RESPONSE TO MAXIMAL ANDROGEN BLOCKADE
Authors: PALMBERG C KOIVISTO P HYYTINEN E ISOLA J VISAKORPI T KALLIONIEMI OP TAMMELA T
Citation: C. Palmberg et al., ANDROGEN RECEPTOR GENE AMPLIFICATION IN A RECURRENT PROSTATE-CANCER AFTER MONOTHERAPY WITH THE NONSTEROIDAL POTENT ANTIANDROGEN CASODEX (BICALUTAMIDE) WITH A SUBSEQUENT FAVORABLE RESPONSE TO MAXIMAL ANDROGEN BLOCKADE, European urology, 31(2), 1997, pp. 216-219
BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE
Authors: OESTERLING JE ROY J AGHA A SHOWN T KRARUP T JOHANSEN T LAGERKVIST M GORMLEY G BACH M WALDSTREICHER J LIEBER M HAMPSEY J POULSEN J EKMAN P JOHANSEN TEB HUDSON PB TAMMELA T MUSTONEN S VARENHORST E HJERTBERG H IMPERATOMCGINLEY J GINGELL JC THOMAS SA WOLF H LANGE P ELLIS W BAERT LVM BARTSCH G BEISLAND HO SUGIMOTO D EINARSON GV NURMI M IVERSEN P TOCKER P MALICE MP
Citation: Je. Oesterling et al., BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE, Urology, 50(1), 1997, pp. 13-18
CHANGE IN LENGTH OF THE DETRUSOR MUSCLE-CELLS
Authors: TAMMELA T
Citation: T. Tammela, CHANGE IN LENGTH OF THE DETRUSOR MUSCLE-CELLS, Scandinavian journal of urology and nephrology, 31, 1997, pp. 19-24
THE 2ND OSLO BIENNIAL SYMPOSIUM ON LOWER URINARY-TRACT PHYSIOLOGY ANDPATHOPHYSIOLOGY - BLADDER CONTRACTILITY - NORMAL EMPTYING AND EMPTYING AGAINST OBSTRUCTION - HOLMENKOLLEN-PARK-HOTEL, 17 AND 18 NOVEMBER 1995 - RUNNING DISCUSSION
Authors: LEVIN RM GABELLA G",TALSETH,ABRAMS,"MORRISON J FRY CH BRADING AF KLEVMARK B TAMMELA T",KRAMER,"UVELIUS B MACARAK E",LINDSTROM,"CHACKO S
Citation: Rm. Levin et al., THE 2ND OSLO BIENNIAL SYMPOSIUM ON LOWER URINARY-TRACT PHYSIOLOGY ANDPATHOPHYSIOLOGY - BLADDER CONTRACTILITY - NORMAL EMPTYING AND EMPTYING AGAINST OBSTRUCTION - HOLMENKOLLEN-PARK-HOTEL, 17 AND 18 NOVEMBER 1995 - RUNNING DISCUSSION, Scandinavian journal of urology and nephrology, 31, 1997, pp. 87-96
A RANDOMIZED STUDY TO COMPARE BIODEGRADABLE SELF-REINFORCED POLYGLYCOLIC ACID SPIRAL STENTS TO SUPRAPUBIC AND INDWELLING CATHETERS AFTER VISUAL LASER-ABLATION OF THE PROSTATE
Authors: PETAS A TALJA M TAMMELA T TAARI K LEHTORANTA K VALIMAA T TORMALA P
Citation: A. Petas et al., A RANDOMIZED STUDY TO COMPARE BIODEGRADABLE SELF-REINFORCED POLYGLYCOLIC ACID SPIRAL STENTS TO SUPRAPUBIC AND INDWELLING CATHETERS AFTER VISUAL LASER-ABLATION OF THE PROSTATE, The Journal of urology, 157(1), 1997, pp. 173-176
ANDROGEN RECEPTOR GENE AMPLIFICATION - A POSSIBLE MOLECULAR MECHANISMFOR ANDROGEN DEPRIVATION THERAPY FAILURE IN PROSTATE-CANCER
Authors: KOIVISTO P KONONEN J PALMBERG C TAMMELA T HYYTINEN E ISOLA J TRAPMAN J CLEUTJENS K NOORDZIJ A VISAKORPI T KALLIONIEMI OP
Citation: P. Koivisto et al., ANDROGEN RECEPTOR GENE AMPLIFICATION - A POSSIBLE MOLECULAR MECHANISMFOR ANDROGEN DEPRIVATION THERAPY FAILURE IN PROSTATE-CANCER, Cancer research, 57(2), 1997, pp. 314-319
REDUCTION OF FLUTAMIDE-INDUCED ALANINE AMINOTRANSFERASE ELEVATION AFTER REPLACEMENT BY BICALUTAMIDE IN A PATIENT WITH N-TREATMENT( DISEASE TREATED WITH MAXIMAL ANDROGEN BLOCKADE AS A PRIMARY)
Authors: PALMBERG C KYLMALA T TAMMELA T
Citation: C. Palmberg et al., REDUCTION OF FLUTAMIDE-INDUCED ALANINE AMINOTRANSFERASE ELEVATION AFTER REPLACEMENT BY BICALUTAMIDE IN A PATIENT WITH N-TREATMENT( DISEASE TREATED WITH MAXIMAL ANDROGEN BLOCKADE AS A PRIMARY), British Journal of Urology, 79(5), 1997, pp. 808-809
ANDROGEN RECEPTOR GENOTYPES AND RISK OF HUMAN PROSTATE-CANCER
Authors: KAARTINEN K SCHLEUTKER J MATIKAINEN M TAMMELA T VISAKORPI T KALLIONIEMI OP
Citation: K. Kaartinen et al., ANDROGEN RECEPTOR GENOTYPES AND RISK OF HUMAN PROSTATE-CANCER, American journal of human genetics, 61(4), 1997, pp. 2120-2120
PROSPECTIVE RANDOMIZED OPEN STUDY BETWEEN CIPROFLOXACIN AND A COMBINATION OF SULFADIAZINE AND TRIMETHOPRIM IN ANTIBIOTIC-PROPHYLAXIS IN CONNECTION WITH TRANSURETHRAL PROSTATECTOMY
Authors: LUKKARINEN O HELLSTROM P LEPPILAHTI M KONTTURI M TAMMELA T
Citation: O. Lukkarinen et al., PROSPECTIVE RANDOMIZED OPEN STUDY BETWEEN CIPROFLOXACIN AND A COMBINATION OF SULFADIAZINE AND TRIMETHOPRIM IN ANTIBIOTIC-PROPHYLAXIS IN CONNECTION WITH TRANSURETHRAL PROSTATECTOMY, Scandinavian journal of urology and nephrology, 30(1), 1996, pp. 33-36
SCREENING FOR PROSTATE-CANCER USING SERUM PROSTATE-SPECIFIC ANTIGEN -A RANDOMIZED, POPULATION-BASED PILOT-STUDY IN FINLAND
Authors: AUVINEN A TAMMELA T STENMAN UH UUSIERKKILA I LEINONEN J SCHRODER FH HAKAMA M
Citation: A. Auvinen et al., SCREENING FOR PROSTATE-CANCER USING SERUM PROSTATE-SPECIFIC ANTIGEN -A RANDOMIZED, POPULATION-BASED PILOT-STUDY IN FINLAND, British Journal of Cancer, 74(4), 1996, pp. 568-572
IN-VIVO AMPLIFICATION OF THE ANDROGEN RECEPTOR GENE AND PROGRESSION OF HUMAN PROSTATE-CANCER
Authors: VISAKORPI T HYYTINEN E KOIVISTO P TANNER M KEINANEN R PALMBERG C PALOTIE A TAMMELA T ISOLA J KALLIONIEMI OP
Citation: T. Visakorpi et al., IN-VIVO AMPLIFICATION OF THE ANDROGEN RECEPTOR GENE AND PROGRESSION OF HUMAN PROSTATE-CANCER, Nature genetics, 9(4), 1995, pp. 401-406
ETIOLOGY OF PRIAPISM IN 207 PATIENTS
Authors: KULMALA R LEHTONEN T NIEMINEN P TAMMELA T
Citation: R. Kulmala et al., ETIOLOGY OF PRIAPISM IN 207 PATIENTS, European urology, 28(3), 1995, pp. 241-245
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
Risultati: 1-25 | 26-31